Point72 Asset Management’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,002,978
Closed -$99.5M 1349
2019
Q3
$99.5M Buy
1,002,978
+999,295
+27,133% +$99.2M 0.61% 34
2019
Q2
$365K Buy
+3,683
New +$351K ﹤0.01% 895
2018
Q3
Sell
-59,400
Closed -$5.55M 1299
2018
Q2
$5.55M Buy
+59,400
New +$5.12M 0.02% 579
2017
Q4
Sell
-77,500
Closed -$5.9M 1161
2017
Q3
$5.9M Buy
77,500
+52,500
+210% +$3.97M 0.03% 510
2017
Q2
$1.88M Sell
25,000
-242,913
-91% -$16.8M 0.01% 662
2017
Q1
$17.5M Sell
267,913
-102,387
-28% -$6.03M 0.1% 272
2016
Q4
$20.4M Buy
+370,300
New +$20.3M 0.14% 184

Other funds holding PRAH

Point72 Asset Management's PRAH Position: Q4 2019 in Review

Point72 Asset Management sold out of PRA Health Sciences, Inc. (PRAH) in Q4 2019, closing a stake of 1,002,978 shares — an estimated $99.5M sold.

Point72 Asset Management first reported a position in PRAH in Q4 2016 and held it in 7 quarters. The position peaked at $99.5M in Q3 2019. 345 funds tracked by Wall St. Rank hold PRAH as of Q4 2019.

  • Point72 Asset Management reported no remaining PRA Health Sciences, Inc. position as of Q4 2019 after selling out during the quarter.
  • Point72 Asset Management sold 1,002,978 PRA Health Sciences, Inc. shares in Q4 2019, an estimated $99.5M.
  • Point72 Asset Management first reported a position in PRA Health Sciences, Inc. in Q4 2016 and held it in 7 quarters.
  • Point72 Asset Management's PRA Health Sciences, Inc. position peaked at $99.5M in Q3 2019.
  • 345 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q4 2019.

Based on Point72 Asset Management's 13F filing for Q4 2019, filed 14 Feb 2020.